image

The best stocks to buy since 1993

Latest issue now available

Anpario

March 2026

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ANP
  • Price:
  • 530p
Anpario, a specialist manufacturer of natural animal feed health additives, has been hitting new highs. This follows the sixth upgrade to FY25 expectations since March 2024.  There was good growth across its regions/operating segments (strongest in Asia, then the Americas, Europe and high growth in India, offset by IMEA noting high comps). The results include a full year from Bio-Vet, which was acquired in September 2024 and has seen one of  its highest ever half-year sales performances through H2 25. Sales are expected to be £47.1m, up 23% or 12% organic.  In light of the statement, Shore Cap has upgraded  EBITDA by 16% to £9.4m and EPS by 15% to 36.9p. FY25 net cash of £12.4m provides ample support for organic investments ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe